Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension

BACKGROUND: This was a phase 3, randomized, double-blind, placebo-controlled study. METHODS: Adult Korean patients with essential hypertension and a baseline mean sitting clinic systolic blood pressure (scSBP) ≥150 and ≤180 mmHg were randomized to 6-week treatment with placebo (n = 65), azilsartan m...

Descripción completa

Detalles Bibliográficos
Autores principales: Juhasz, Attila, Wu, Jingtao, Hisada, Michie, Tsukada, Tomoka, Jeong, Myung Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804062/
https://www.ncbi.nlm.nih.gov/pubmed/29445520
http://dx.doi.org/10.1186/s40885-018-0086-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804062/
https://www.ncbi.nlm.nih.gov/pubmed/29445520
http://dx.doi.org/10.1186/s40885-018-0086-4

Ejemplares similares